Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Entero Therapeutics Inc (NASDAQ: ENTO) was $0.59 for the day, up 10.05% from the previous closing price of $0.54. In other words, the price has increased by $10.05 from its previous closing price. On the day, 0.73 million shares were traded.
Ratios:
Our analysis of ENTO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 2.90. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’25 when Romano Sarah sold 727 shares for $0.64 per share. The transaction valued at 465 led to the insider holds 17,287 shares of the business.
Romano Sarah sold 476 shares of ENTO for $212 on Oct 09 ’24. The Chief Financial Officer now owns 18,014 shares after completing the transaction at $0.45 per share. On Jul 02 ’24, another insider, Romano Sarah, who serves as the Chief Financial Officer of the company, sold 621 shares for $1.07 each. As a result, the insider received 664 and left with 18,490 shares of the company.
Stock Price History:
Over the past 52 weeks, ENTO has reached a high of $2.46, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is 42.40%, while the 200-Day Moving Average is calculated to be 19.60%.
Shares Statistics:
A total of 4.77M shares are outstanding, with a floating share count of 4.67M. Insiders hold about 1.97% of the company’s shares, while institutions hold 2.97% stake in the company.
